Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic breast cancer: a randomized, open-label, non-inferiority Phase III trial.
Onco Targets Ther
; 9: 4173-80, 2016.
Article
in En
| MEDLINE
| ID: mdl-27468239
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
Language:
En
Journal:
Onco Targets Ther
Year:
2016
Document type:
Article
Country of publication:
Nueva Zelanda